1. Sun, Wei, Jin, Yongjia, Wei, Chuanyuan, Xiang, Yang, Chen, Yong. 2023. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A. In European journal of cancer (Oxford, England : 1990), 188, 49-63. doi:10.1016/j.ejca.2023.04.005. https://pubmed.ncbi.nlm.nih.gov/37196484/
2. Yu, Zhenjun, Zhang, Yu, Shao, Shuai, Hong, Wei, Han, Tao. 2021. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. In Frontiers in oncology, 11, 755814. doi:10.3389/fonc.2021.755814. https://pubmed.ncbi.nlm.nih.gov/34660326/
3. Xu, Bing, Chen, Hui, Xu, Zhipeng, Sun, Xinchen, Cheng, Hongyan. 2021. CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells. In Molecular medicine reports, 24, . doi:10.3892/mmr.2021.12169. https://pubmed.ncbi.nlm.nih.gov/34036376/
4. Li, Kai, Fan, Tingting, Shi, Zhongxing, Jiang, Huijie. 2022. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway. In Analytical cellular pathology (Amsterdam), 2022, 9912254. doi:10.1155/2022/9912254. https://pubmed.ncbi.nlm.nih.gov/36588796/
5. Tang, Mengying, Liao, Mingchu, Ai, Xiaohong, He, Guicheng. 2022. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints. In Frontiers in medicine, 8, 773724. doi:10.3389/fmed.2021.773724. https://pubmed.ncbi.nlm.nih.gov/35372372/
6. Liu, Luyu, Yin, Pan, Yang, Ruida, Wu, Shaobo, Liu, Meng. 2024. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma. In Frontiers in immunology, 15, 1351908. doi:10.3389/fimmu.2024.1351908. https://pubmed.ncbi.nlm.nih.gov/38863714/
7. Chen, Chongxiang, Chen, Siliang, Luo, Ma, Lai, Jielan, Li, Huan. . The role of the CDCA gene family in ovarian cancer. In Annals of translational medicine, 8, 190. doi:10.21037/atm.2020.01.99. https://pubmed.ncbi.nlm.nih.gov/32309337/
8. Shi, Run, Zhang, Chunrong, Wu, Yaqin, Jiang, Feng, Xu, Lin. . CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients. In Oncotarget, 8, 19768-19779. doi:10.18632/oncotarget.15519. https://pubmed.ncbi.nlm.nih.gov/28423619/